Luis M Molinos-Albert

Barcelona Institute for Global Health

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Josep Vidal-Alaball

Adjunct Professor

Universitat de Vic - Universitat Central de Catalunya

SPAIN

View details

Jordan D. Dimitrov

Sorbonne Université

FRANCE

View details

Carlota Dobaño Lazaro

Research Professor

Instituto de Salud Global Barcelona

SPAIN

View details

Dídac Macià Bros

Barcelona Institute for Global Health

SPAIN

View details

ANNA RUIZ COMELLAS

Professora associada

Universitat de Vic - Universitat Central de Catalunya

SPAIN

View details

Hugo MOUQUET

Université Paris Cité

FRANCE

View details

Asier Sáez-Cirión

Institut Pasteur

FRANCE

View details

Eduard Baquero

Institut Pasteur

FRANCE

View details

Maxime HENTZIEN

Full Professor in Infectious Diseases

Université de Reims Champagne-Ardenne

FRANCE

View details

Pablo Guardado-Calvo

Université Paris Cité

FRANCE

View details

Alexia Tavares

Centre Georges-François Leclerc

FRANCE

View details

Julià Blanco

Associate Professor

Universitat de Vic - Universitat Central de Catalunya

SPAIN

View details

Emilie Giraud

Institut Pasteur

FRANCE

View details

Olivier Schwartz

FRANCE

View details

Fabrice AGOU

Head of Chemogenomic and Biological screening core facility

Institut Pasteur

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luis M Molinos-Albert

Research Interests

Explore related searches

Contact this professor

Articles (13)

Structural Basis for Hepatitis E Virus Neutralization by Potent Human Antibodies

Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections

Antibody and B‐Cell Responses to PHH‐1V81 XBB.1.16‐Adapted SARS‐CoV‐2 Booster Vaccination Are Associated With Variant Neutralization

Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later

The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01<sub>E</sub> vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial

High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination

Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings

Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller

An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses

HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria

Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers

Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller

Collaborators (15)

Josep Vidal-Alaball

Jordan D. Dimitrov

Carlota Dobaño Lazaro

Dídac Macià Bros

ANNA RUIZ COMELLAS

Hugo MOUQUET

Asier Sáez-Cirión

Eduard Baquero

Maxime HENTZIEN

Pablo Guardado-Calvo

Alexia Tavares

Julià Blanco

Emilie Giraud

Olivier Schwartz

Fabrice AGOU

Make your next move.